Viewing Study NCT04512261

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:46 AM
Ignite Modification Date: 2026-01-27 @ 12:04 PM
Study NCT ID: NCT04512261
Status: WITHDRAWN
Last Update Posted: 2022-07-01
First Post: 2020-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases
Sponsor: Reva Basho
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Brain Metastases View
None HER2-positive Breast Cancer View
None CNS Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None tucatinib View
None pembrolizumab View
None trastuzumab View